Prioritising for a data-driven 2023
European Pharmaceutical Review
MARCH 2, 2023
Specifically, we can expect clinical trial innovation to continue apace; defined next steps toward IDMP implementation in the EU and US (beyond the immediate DADI-based Marketing Authorization submissions process); as well as further clarifications on electronic Product Information (ePI) and serialisation.
84 
Let's personalize your content